Fritz, V.; Malek, L.; Gaza, A.; Wormser, L.; Appel, M.; Kremer, A.E.; Thasler, W.E.; Siebler, J.; Neurath, M.F.; Hellerbrand, C.;
et al. Combined De-Repression of Chemoresistance Associated Mitogen-Activated Protein Kinase 14 and Activating Transcription Factor 2 by Loss of microRNA-622 in Hepatocellular Carcinoma. Cancers 2021, 13, 1183.
https://doi.org/10.3390/cancers13051183
AMA Style
Fritz V, Malek L, Gaza A, Wormser L, Appel M, Kremer AE, Thasler WE, Siebler J, Neurath MF, Hellerbrand C,
et al. Combined De-Repression of Chemoresistance Associated Mitogen-Activated Protein Kinase 14 and Activating Transcription Factor 2 by Loss of microRNA-622 in Hepatocellular Carcinoma. Cancers. 2021; 13(5):1183.
https://doi.org/10.3390/cancers13051183
Chicago/Turabian Style
Fritz, Valerie, Lara Malek, Anne Gaza, Laura Wormser, Majken Appel, Andreas E. Kremer, Wolfgang E. Thasler, Jürgen Siebler, Markus F. Neurath, Claus Hellerbrand,
and et al. 2021. "Combined De-Repression of Chemoresistance Associated Mitogen-Activated Protein Kinase 14 and Activating Transcription Factor 2 by Loss of microRNA-622 in Hepatocellular Carcinoma" Cancers 13, no. 5: 1183.
https://doi.org/10.3390/cancers13051183
APA Style
Fritz, V., Malek, L., Gaza, A., Wormser, L., Appel, M., Kremer, A. E., Thasler, W. E., Siebler, J., Neurath, M. F., Hellerbrand, C., Bosserhoff, A. K., & Dietrich, P.
(2021). Combined De-Repression of Chemoresistance Associated Mitogen-Activated Protein Kinase 14 and Activating Transcription Factor 2 by Loss of microRNA-622 in Hepatocellular Carcinoma. Cancers, 13(5), 1183.
https://doi.org/10.3390/cancers13051183